Hongyan Wei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hongyan Wei has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Chunlin Hu
Department of Emergency Medicine, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, People’s Republic of China
5 shared publications - Cong Liu
Department of Emergency Medicine, The Fourth Affiliated of Soochow University (Suzhou Dushu Lake Hospital), Suzhou, 215009, China
3 shared publications - Zhang
Department of Emergency Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
3 shared publications - Bo Li
Department of Emergency Medicine, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China
2 shared publications - Chuyue Wang
Department of Emergency Medicine, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China
2 shared publications - Dawang Zhou
Department of Emergency Medicine, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China
2 shared publications
Latest Publications
- Open Access
- 22 July 2026
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 13, 1835581
Prognostic value and clinical net benefit of global longitudinal strain in sepsis: a prospective study with internal bootstrap validation
Objective: Conventional left ventricular ejection fraction (LVEF) often fails to detect early sepsis-induced myocardial dysfunction (SIMD). This study aimed to evaluate the prognostic utility of speckle-tracking echocardiography (STE)-derived global longitudinal strain (GLS) and to develop an internally validated clinical nomogram with demonstrated net benefit for predicting 28-day mortality in sepsis patients. Methods: This prospective observational study enrolled 46 patients presenting with sepsis or septic shock at the Emergency Department of The First Affiliated Hospital of Sun Yat-sen University (February–June 2023). STE-derived average GLS (GLS_AVG), conventional echocardiography, and cardiac biomarkers were evaluated within 24 h of diagnosis. Prognostic performance was assessed using restricted multivariable logistic regression, Receiver Operating Characteristic (ROC) curves, and DeLong's test. A predictive nomogram was constructed, validated via 1,000 bootstrap resamples, and evaluated for clinical utility using Decision Curve Analysis (DCA). Results: The 28-day mortality rate was 23.9% (11/46). Compared to survivors, non-survivors exhibited significantly impaired GLS_AVG (−10.09 ± 4.18% vs. −14.69 ± 3.13%, P < 0.001) and higher SOFA scores (11.55 ± 3.11 vs. 7.63 ± 3.15, P = 0.001). GLS_AVG strongly correlated with SOFA ( r = 0.663) and NT-proBNP peak ( r = 0.424). ROC analysis demonstrated that GLS_AVG (AUC: 0.796) outperformed conventional LVEF (AUC: 0.706) in predicting mortality. The optimal GLS_AVG cutoff was > −11.0% (sensitivity 72.7%, specificity 82.9%). In restricted multivariable analysis, GLS_AVG showed a borderline independent association with 28-day mortality in the restricted multivariable model (OR: 1.266; 95% CI: 0.995–1.676; P = 0.067). The formulated GLS-SOFA nomogram showed excellent calibration upon 1,000-bootstrap internal validation. Crucially, DCA confirmed that integrating GLS yielded a substantially higher clinical net benefit across a wide range of threshold probabilities compared to relying on LVEF alone. Conclusion: STE-derived GLS is a highly sensitive, relatively load-independent marker of early myocardial dysfunction in sepsis, significantly outperforming LVEF in predicting 28-day mortality. The validated GLS-SOFA nomogram and decision curve models provide a practical, high-yield tool to enhance risk stratification and guide early personalized hemodynamic resuscitation in emergency settings.
- 22 July 2026
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 13, 1835581
Open AccessPrognostic value and clinical net benefit of global longitudinal strain in sepsis: a prospective study with internal bootstrap validation
Objective: Conventional left ventricular ejection fraction (LVEF) often fails to detect early sepsis-induced myocardial dysfunction (SIMD). This study aimed to evaluate the prognostic utility of speckle-tracking echocardiography (STE)-derived global longitudinal strain (GLS) and to develop an internally validated clinical nomogram with demonstrated net benefit for predicting 28-day mortality in sepsis patients. Methods: This prospective observational study enrolled 46 patients presenting with sepsis or septic shock at the Emergency Department of The First Affiliated Hospital of Sun Yat-sen University (February–June 2023). STE-derived average GLS (GLS_AVG), conventional echocardiography, and cardiac biomarkers were evaluated within 24 h of diagnosis. Prognostic performance was assessed using restricted multivariable logistic regression, Receiver Operating Characteristic (ROC) curves, and DeLong's test. A predictive nomogram was constructed, validated via 1,000 bootstrap resamples, and evaluated for clinical utility using Decision Curve Analysis (DCA). Results: The 28-day mortality rate was 23.9% (11/46). Compared to survivors, non-survivors exhibited significantly impaired GLS_AVG (−10.09 ± 4.18% vs. −14.69 ± 3.13%, P < 0.001) and higher SOFA scores (11.55 ± 3.11 vs. 7.63 ± 3.15, P = 0.001). GLS_AVG strongly correlated with SOFA ( r = 0.663) and NT-proBNP peak ( r = 0.424). ROC analysis demonstrated that GLS_AVG (AUC: 0.796) outperformed conventional LVEF (AUC: 0.706) in predicting mortality. The optimal GLS_AVG cutoff was > −11.0% (sensitivity 72.7%, specificity 82.9%). In restricted multivariable analysis, GLS_AVG showed a borderline independent association with 28-day mortality in the restricted multivariable model (OR: 1.266; 95% CI: 0.995–1.676; P = 0.067). The formulated GLS-SOFA nomogram showed excellent calibration upon 1,000-bootstrap internal validation. Crucially, DCA confirmed that integrating GLS yielded a substantially higher clinical net benefit across a wide range of threshold probabilities compared to relying on LVEF alone. Conclusion: STE-derived GLS is a highly sensitive, relatively load-independent marker of early myocardial dysfunction in sepsis, significantly outperforming LVEF in predicting 28-day mortality. The validated GLS-SOFA nomogram and decision curve models provide a practical, high-yield tool to enhance risk stratification and guide early personalized hemodynamic resuscitation in emergency settings.
- 19 May 2026
- Published by Elsevier in Journal of Hazardous Materials
- Vol. 512, 142443
Multimodal detection of microplastics in human kidney stones and multi-omics exploration of renal cell metaflammation
- 19 May 2026
- Published by Elsevier in Journal of Hazardous Materials
- Vol. 512, 142443
Multimodal detection of microplastics in human kidney stones and multi-omics exploration of renal cell metaflammation
- Open Access
- 1 May 2025
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (5) , 3032-3052
Association between red blood cell distribution width to albumin ratio (RAR) and long-term prognosis of patients with sudden cardiac arrest
Background: Red blood cell distribution width to albumin ratio (RAR) is associated with adverse outcomes in a variety of clinical conditions. However, the potential connection between RAR and the prognostic outcome of patients with sudden cardiac arrest (CA) remains uncharted. Hence, this study emphasizes elucidating the relevance between RAR and adverse prognosis in patients with sudden CA. Methods: Our study, a retrospective cohort analysis, used data from the Medical Information Mart for Intensive Care IV (MIMIC-IV) version 3.0 database. The 1-year mortality rate was the principal endpoint of this study, the subordinate outcomes included the 5-year, 28-day, 90-day, and in-hospital mortality rates. Cox models, cubic spline models, and subgroup analyses assessed the link between RAR and mortality rates. Results: This study included a total of 1,673 participants. The study found that in the groups with in-hospital, 28-day, 90-day, 1-year and 5-year death rates, the median RAR of those who passed away was notably higher than that of those who survived. When the participants were grouped based on RAR tripartite number, it was observed that in the higher RAR groups, the numbers of deaths at various intervals (in-hospital, 28-day, 90-day, 1-year, and 5-year) showed significant increases. After adjusting for other factors, it was discovered that for the 1-year death rate, the risk was 1.27 times higher in the Q2 group (4.51–5.77) and 1.42 times higher in the Q3 group (>5.77) (with a confidence level of 95%), showing statistical significance. Similar patterns were found in the 28-day, 90-day, and 5-year death rates. However, this pattern was not seen in patients with in-hospital mortality. Besides, the analysis indicated a significant nonlinear relationship between RAR and the 1-year, 5-year death rate. The model constructed using the variables selected through least absolute shrinkage and selection operator (Lasso) regression analysis for predicting the clinical prognosis of patients with sudden CA demonstrated good discriminative ability, accuracy, and clinical utility. Conclusions: Our research has found a close association between RAR and the long-term adverse clinical outcomes of patients with sudden CA. The higher the RAR, the higher the mortality rates at 28 days, 90 days, 1 year and 5 years. A clinical model based on RAR for predicting the prognosis of patients with sudden CA can provide a convenient and accurate scoring system for evaluating their prognosis.
- 1 May 2025
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (5) , 3032-3052
Open AccessAssociation between red blood cell distribution width to albumin ratio (RAR) and long-term prognosis of patients with sudden cardiac arrest
Background: Red blood cell distribution width to albumin ratio (RAR) is associated with adverse outcomes in a variety of clinical conditions. However, the potential connection between RAR and the prognostic outcome of patients with sudden cardiac arrest (CA) remains uncharted. Hence, this study emphasizes elucidating the relevance between RAR and adverse prognosis in patients with sudden CA. Methods: Our study, a retrospective cohort analysis, used data from the Medical Information Mart for Intensive Care IV (MIMIC-IV) version 3.0 database. The 1-year mortality rate was the principal endpoint of this study, the subordinate outcomes included the 5-year, 28-day, 90-day, and in-hospital mortality rates. Cox models, cubic spline models, and subgroup analyses assessed the link between RAR and mortality rates. Results: This study included a total of 1,673 participants. The study found that in the groups with in-hospital, 28-day, 90-day, 1-year and 5-year death rates, the median RAR of those who passed away was notably higher than that of those who survived. When the participants were grouped based on RAR tripartite number, it was observed that in the higher RAR groups, the numbers of deaths at various intervals (in-hospital, 28-day, 90-day, 1-year, and 5-year) showed significant increases. After adjusting for other factors, it was discovered that for the 1-year death rate, the risk was 1.27 times higher in the Q2 group (4.51–5.77) and 1.42 times higher in the Q3 group (>5.77) (with a confidence level of 95%), showing statistical significance. Similar patterns were found in the 28-day, 90-day, and 5-year death rates. However, this pattern was not seen in patients with in-hospital mortality. Besides, the analysis indicated a significant nonlinear relationship between RAR and the 1-year, 5-year death rate. The model constructed using the variables selected through least absolute shrinkage and selection operator (Lasso) regression analysis for predicting the clinical prognosis of patients with sudden CA demonstrated good discriminative ability, accuracy, and clinical utility. Conclusions: Our research has found a close association between RAR and the long-term adverse clinical outcomes of patients with sudden CA. The higher the RAR, the higher the mortality rates at 28 days, 90 days, 1 year and 5 years. A clinical model based on RAR for predicting the prognosis of patients with sudden CA can provide a convenient and accurate scoring system for evaluating their prognosis.
- Open Access
- 20 June 2023
- Published by Springer Nature in Neurochemical Research
- Vol. 48 (10) , 3129-3145
Targeted Activation of HNF4α by AMPK Inhibits Apoptosis and Ameliorates Neurological Injury Caused by Cardiac Arrest in Rats
Previous studies have shown that AMPK plays an important role in cerebral ischemia–reperfusion injury by participating in apoptosis, but the exact mechanism and target of action remains unclear. This study aimed to investigate the protective mechanism of AMPK activation on brain injury secondary to cardiac arrest. HE, Nills and TUNEL assays were used to evaluate neuronal damage and apoptosis. The relationships between AMPK, HNF4α and apoptotic genes were verified by ChIP-seq, dual-luciferase and WB assays. The results showed that AMPK improved the 7-day memory function of rats, and reduced neuronal cell injury and apoptosis in the hippocampal CA1 region after ROSC, while the use of HNF4α inhibitor weakened the protective effect of AMPK. Further research found that AMPK positively regulated the expression of HNF4α, and AMPK could promote the expression of Bcl-2 and inhibit the expression of Bax and Cleaved-Caspase 3. In vitro experiments showed that AMPK ameliorated neuronal injury by inhibiting apoptosis through the activation of HNF4α. Combined with ChIP-seq, JASPAR analysis and Dual-luciferase assay, the binding site of HNF4α to the upstream promoter of Bcl-2 was found. Taken together, AMPK attenuates brain injury after CA by activating HNF4α to target Bcl-2 to inhibit apoptosis.
- 20 June 2023
- Published by Springer Nature in Neurochemical Research
- Vol. 48 (10) , 3129-3145
Open AccessTargeted Activation of HNF4α by AMPK Inhibits Apoptosis and Ameliorates Neurological Injury Caused by Cardiac Arrest in Rats
Previous studies have shown that AMPK plays an important role in cerebral ischemia–reperfusion injury by participating in apoptosis, but the exact mechanism and target of action remains unclear. This study aimed to investigate the protective mechanism of AMPK activation on brain injury secondary to cardiac arrest. HE, Nills and TUNEL assays were used to evaluate neuronal damage and apoptosis. The relationships between AMPK, HNF4α and apoptotic genes were verified by ChIP-seq, dual-luciferase and WB assays. The results showed that AMPK improved the 7-day memory function of rats, and reduced neuronal cell injury and apoptosis in the hippocampal CA1 region after ROSC, while the use of HNF4α inhibitor weakened the protective effect of AMPK. Further research found that AMPK positively regulated the expression of HNF4α, and AMPK could promote the expression of Bcl-2 and inhibit the expression of Bax and Cleaved-Caspase 3. In vitro experiments showed that AMPK ameliorated neuronal injury by inhibiting apoptosis through the activation of HNF4α. Combined with ChIP-seq, JASPAR analysis and Dual-luciferase assay, the binding site of HNF4α to the upstream promoter of Bcl-2 was found. Taken together, AMPK attenuates brain injury after CA by activating HNF4α to target Bcl-2 to inhibit apoptosis.
- Open Access
- 20 October 2022
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 43 (5) , 2179-2202
Neuroprotective Effect of miR-483-5p Against Cardiac Arrest-Induced Mitochondrial Dysfunction Mediated Through the TNFSF8/AMPK/JNK Signaling Pathway
Substantial morbidity and mortality are associated with postcardiac arrest brain injury (PCABI). MicroRNAs(miRNAs) are essential regulators of neuronal metabolism processes and have been shown to contribute to alleviated neurological injury after cardiac arrest. In this study, we identified miRNAs related to the prognosis of patients with neurological dysfunction after cardiopulmonary resuscitation based on data obtained from the Gene Expression Omnibus (GEO) database. Then, we explored the effects of miR-483-5p on mitochondrial biogenesis, mitochondrial-dependent apoptosis, and oxidative stress levels after ischemia‒reperfusion injury in vitro and in vivo. MiR-483-5p was downregulated in PC12 cells and hippocampal samples compared with that in normal group cells and hippocampi. Overexpression of miR-483-5p increased the viability of PC12 cells after ischemia‒reperfusion injury and reduced the proportion of dead cells. A western blot analysis showed that miR-483-5p increased the protein expression of PCG-1, NRF1, and TFAM and reduced the protein expression of Bax and cleaved caspase 3, inhibiting the release of cytochrome c from mitochondria and alleviating oxidative stress injury by inhibiting the production of ROS and reducing MDA activity. We confirmed that miR-483-5p targeted TNFSF8 to regulate the AMPK/JNK pathway, thereby playing a neuroprotective role after cardiopulmonary resuscitation. Hence, this study provides further insights into strategies for inhibiting neurological impairment after cardiopulmonary resuscitation and suggests a potential therapeutic target for PCABI.
- 20 October 2022
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 43 (5) , 2179-2202
Open AccessNeuroprotective Effect of miR-483-5p Against Cardiac Arrest-Induced Mitochondrial Dysfunction Mediated Through the TNFSF8/AMPK/JNK Signaling Pathway
Substantial morbidity and mortality are associated with postcardiac arrest brain injury (PCABI). MicroRNAs(miRNAs) are essential regulators of neuronal metabolism processes and have been shown to contribute to alleviated neurological injury after cardiac arrest. In this study, we identified miRNAs related to the prognosis of patients with neurological dysfunction after cardiopulmonary resuscitation based on data obtained from the Gene Expression Omnibus (GEO) database. Then, we explored the effects of miR-483-5p on mitochondrial biogenesis, mitochondrial-dependent apoptosis, and oxidative stress levels after ischemia‒reperfusion injury in vitro and in vivo. MiR-483-5p was downregulated in PC12 cells and hippocampal samples compared with that in normal group cells and hippocampi. Overexpression of miR-483-5p increased the viability of PC12 cells after ischemia‒reperfusion injury and reduced the proportion of dead cells. A western blot analysis showed that miR-483-5p increased the protein expression of PCG-1, NRF1, and TFAM and reduced the protein expression of Bax and cleaved caspase 3, inhibiting the release of cytochrome c from mitochondria and alleviating oxidative stress injury by inhibiting the production of ROS and reducing MDA activity. We confirmed that miR-483-5p targeted TNFSF8 to regulate the AMPK/JNK pathway, thereby playing a neuroprotective role after cardiopulmonary resuscitation. Hence, this study provides further insights into strategies for inhibiting neurological impairment after cardiopulmonary resuscitation and suggests a potential therapeutic target for PCABI.
- Open Access
- 15 July 2022
- Published by MDPI AG in Brain Sciences
- Vol. 12 (7) , 928
Identification and Validation of Novel Potential Pathogenesis and Biomarkers to Predict the Neurological Outcome after Cardiac Arrest
Predicting neurological outcomes after cardiac arrest remains a major issue. This study aimed to identify novel biomarkers capable of predicting neurological prognosis after cardiac arrest. Expression profiles of GSE29540 and GSE92696 were downloaded from the Gene Expression Omnibus (GEO) database to obtain differentially expressed genes (DEGs) between high and low brain performance category (CPC) scoring subgroups. Weighted gene co-expression network analysis (WGCNA) was used to screen key gene modules and crossover genes in these datasets. The protein-protein interaction (PPI) network of crossover genes was constructed from the STRING database. Based on the PPI network, the most important hub genes were identified by the cytoHubba plugin of Cytoscape software. Eight hub genes (RPL27, EEF1B2, PFDN5, RBX1, PSMD14, HINT1, SNRPD2, and RPL26) were finally screened and validated, which were downregulated in the group with poor neurological prognosis. In addition, GSEA identified critical pathways associated with these genes. Finally, a Pearson correlation analysis showed that the mRNA expression of hub genes EEF1B2, PSMD14, RPFDN5, RBX1, and SNRPD2 were significantly and positively correlated with NDS scores in rats. Our work could provide comprehensive insights into understanding pathogenesis and potential new biomarkers for predicting neurological outcomes after cardiac arrest.
- 15 July 2022
- Published by MDPI AG in Brain Sciences
- Vol. 12 (7) , 928
Open AccessIdentification and Validation of Novel Potential Pathogenesis and Biomarkers to Predict the Neurological Outcome after Cardiac Arrest
Predicting neurological outcomes after cardiac arrest remains a major issue. This study aimed to identify novel biomarkers capable of predicting neurological prognosis after cardiac arrest. Expression profiles of GSE29540 and GSE92696 were downloaded from the Gene Expression Omnibus (GEO) database to obtain differentially expressed genes (DEGs) between high and low brain performance category (CPC) scoring subgroups. Weighted gene co-expression network analysis (WGCNA) was used to screen key gene modules and crossover genes in these datasets. The protein-protein interaction (PPI) network of crossover genes was constructed from the STRING database. Based on the PPI network, the most important hub genes were identified by the cytoHubba plugin of Cytoscape software. Eight hub genes (RPL27, EEF1B2, PFDN5, RBX1, PSMD14, HINT1, SNRPD2, and RPL26) were finally screened and validated, which were downregulated in the group with poor neurological prognosis. In addition, GSEA identified critical pathways associated with these genes. Finally, a Pearson correlation analysis showed that the mRNA expression of hub genes EEF1B2, PSMD14, RPFDN5, RBX1, and SNRPD2 were significantly and positively correlated with NDS scores in rats. Our work could provide comprehensive insights into understanding pathogenesis and potential new biomarkers for predicting neurological outcomes after cardiac arrest.
- Open Access
- 1 January 2020
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 53 (1) , e9136
Enhanced external counterpulsation improves cardiac function in Beagles after cardiopulmonary resuscitation
The aim of this study was to investigate the influence of enhanced external counterpulsation (EECP) on the cardiac function of beagle dogs after prolonged ventricular fibrillation. Twenty-four adult male beagles were randomly divided into control and EECP groups. Ventricular fibrillation was induced in the animals for 12 min, followed by 2 min of cardiopulmonary resuscitation. They then received EECP therapy for 4 h (EECP group) or not (control group). The hemodynamics was monitored using the PiCCO2 system. Blood gas and hemorheology were assessed at baseline and at 1, 2, and 4 h after return of spontaneous circulation (ROSC). The myocardial blood flow (MBF) was quantified by 18F-flurpiridaz PET myocardial perfusion imaging at baseline and 4 h after ROSC. Survival time of the animals was recorded within 24 h. Ventricular fibrillation was successfully induced in all animals, and they achieved ROSC after cardiopulmonary resuscitation. Survival time of the control group was shorter than that of the EECP group [median of 8 h (min 8 h, max 21 h) vs median of 24 h (min 16 h, max 24 h) (Kaplan Meyer plot analysis, P=0.0152). EECP improved blood gas analysis findings and increased the coronary perfusion pressure and MBF value. EECP also improved the cardiac function of Beagles after ROSC in multiple aspects, significantly increased blood flow velocity, and decreased plasma viscosity, erythrocyte aggregation index, and hematocrit levels. EECP improved the hemodynamics of beagle dogs and increased MBF, subsequently improving cardiac function and ultimately improving the survival time of animals after ROSC.
- 1 January 2020
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 53 (1) , e9136
Open AccessEnhanced external counterpulsation improves cardiac function in Beagles after cardiopulmonary resuscitation
The aim of this study was to investigate the influence of enhanced external counterpulsation (EECP) on the cardiac function of beagle dogs after prolonged ventricular fibrillation. Twenty-four adult male beagles were randomly divided into control and EECP groups. Ventricular fibrillation was induced in the animals for 12 min, followed by 2 min of cardiopulmonary resuscitation. They then received EECP therapy for 4 h (EECP group) or not (control group). The hemodynamics was monitored using the PiCCO2 system. Blood gas and hemorheology were assessed at baseline and at 1, 2, and 4 h after return of spontaneous circulation (ROSC). The myocardial blood flow (MBF) was quantified by 18F-flurpiridaz PET myocardial perfusion imaging at baseline and 4 h after ROSC. Survival time of the animals was recorded within 24 h. Ventricular fibrillation was successfully induced in all animals, and they achieved ROSC after cardiopulmonary resuscitation. Survival time of the control group was shorter than that of the EECP group [median of 8 h (min 8 h, max 21 h) vs median of 24 h (min 16 h, max 24 h) (Kaplan Meyer plot analysis, P=0.0152). EECP improved blood gas analysis findings and increased the coronary perfusion pressure and MBF value. EECP also improved the cardiac function of Beagles after ROSC in multiple aspects, significantly increased blood flow velocity, and decreased plasma viscosity, erythrocyte aggregation index, and hematocrit levels. EECP improved the hemodynamics of beagle dogs and increased MBF, subsequently improving cardiac function and ultimately improving the survival time of animals after ROSC.
- 1 June 2018
- Published by Elsevier in Resuscitation
- Vol. 127, 68-72
Out-of-hospital cardiac arrest with Do-Not-Resuscitate orders signed in hospital: Who are the survivors?
- 1 June 2018
- Published by Elsevier in Resuscitation
- Vol. 127, 68-72
Out-of-hospital cardiac arrest with Do-Not-Resuscitate orders signed in hospital: Who are the survivors?